Pfizer Inc
(WBO:PFE)
€
24.61
-0.23 (-0.93%)
Market Cap: 139.23 Bil
Enterprise Value: 192.39 Bil
PE Ratio: 35.39
PB Ratio: 1.61
GF Score: 77/100 
Pfizer Inc at Morgan Stanley Healthcare Conference Transcript
Sep 09, 2019 / 07:40PM GMT
Release Date Price:
€31.02
(-0.70%)
David Reed Risinger
Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst
So thanks, everyone, for joining us for the Pfizer session. I just need to refer you to disclaimers at www.morganstanley.com/researchdisclosures. It's my pleasure to welcome Frank D'Amelio. He is Executive Vice President of Business Operations and Chief Financial Officer, and he's been with the company now 12 years, so time flies. But I thought it would be great to have you, Frank, start with a few opening remarks, and then we'll take it from there.
Frank A. D;Amelio
Pfizer Inc. - CFO & EVP of Global Supply & Business Operations
' -
Just I think this is, what, the third or fourth year in a row you and I have done this conference?
David Reed Risinger;Frank A. D<
Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst
Yes.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers